Healthcare

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 17 Mar 2026  |  Global  |  Market Research

    Growth Opportunities in Global Pharmaceutical Industry, 2026

    Platforms, Policies, and Pathways: Convert Complexity into Growth

    The global pharmaceutical market is projected to reach approximately $1.72 trillion in 2026, with large molecules driving most incremental growth while small molecules remain the sector’s cash flow base. The current growth cycle concentrates on cardiometabolic and oncology, led by GLP-1 platforms and antibody–drug conjugates (ADCs). Competitive adv...

    $4,950.00
  2. 25 Feb 2026  |  Global  |  Technology Research

    Growth Opportunities in Microbiome Technologies in Consumer Wellness, 2026–2030

    Emerging Interest from Industry Players Is Boosting Growth in the Evolving Microbiome-Based Consumer Wellness Industry

    The microbiome sector is a core component of the self-care movement, promoting proactive health behaviors. The gut microbiota is now recognized as an organ-like system that influences overall health and specific medical conditions, making continued advancement critical to enhancing well-being.The consumer wellness industry is evolving alongside gro...

    $4,950.00
  3. 20 Feb 2026  |  Global  |  Technology Research

    Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...

    $950.00
  4. 17 Feb 2026  |  Global  |  Market Research

    Global Precision Cardiology Market: Trends and Growth Opportunities

    Cross-industry Collaborations and Adoption of Cutting-edge Digital Tools and Technologies are Propelling Market Growth

    Cardiovascular diseases (CVDs) remain the leading cause of global morbidity and mortality, with reported cases having doubled since 1990. Today, CVDs account for 1 in 3 deaths worldwide, representing 32% of total global mortality, with heart attacks and ischemic strokes responsible for approximately 85% of these outcomes. The rising burden is stron...

    $2,450.00
  5. 23 Jan 2026  |  Global  |  Technology Research

    Next-Generation Therapeutic Platforms: AI-Enabled Drug Discovery, Small molecules, Deep Proteomics, RNA Engineering, and Targeted Immunomodulation

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers provides strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision therapeutics. It highlights advances in AI-enabled diagnostics, metabolic reprogramming, small molecules, deep proteomics, RNA disco...

    $950.00
  6. 19 Dec 2025  |  Global  |  Technology Research

    Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine

    Life Science, Health & Wellness Technology Opportunity Engine

    This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...

    $950.00
  7. 18 Dec 2025  |  Global  |  Market Research

    Growth Opportunities in Cell and Gene Therapeutics Market, Forecast to 2030

    Platform Innovation, Regulatory Maturity, and Global Capacity Expansion Are Catalyzing the Next Wave of Growth in Cell and Gene Therapy

    The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

    $4,950.00
  8. 02 Dec 2025  |  Global  |  Frost Radar

    Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...

    $4,950.00
  9. 26 Nov 2025  |  Global  |  Market Research

    Future of Bio-Pharma Industry, 2040

    Adoption of Artificial Intelligence Is Driving Transformational Growth Across the Biopharma Value Chain

    The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...

    $2,450.00
  10. 11 Nov 2025  |  Global  |  Technology Research

    Frost Radar™: Digital Biomanufacturing of Viral Vectors, 2025

    A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

    Viral vectors are a critical part of gene therapies and genetic medicines, which are the cornerstone of precision medicines to cure rare diseases, cancers, and genetic disorders. Traditional bioprocessing, however, is tedious, less flexible, batch-based, and heavily manual; as a result, manufacturing processes involve high costs, scalability issues...

    $4,950.00